Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/2003
11/26/2003CN1457766A Mucilage antiseptic medicine composition capable of being locally administratied and sustainably released and its preparing method
11/26/2003CN1457761A Bagged dry powder with polyphenols plant extracts as raw materials
11/26/2003CN1457705A Process for producing Haoyin companion
11/26/2003CN1128810C Polypeptide structure of shark liver of preventing and curing hepatitis and its purifying process
11/26/2003CN1128800C Pyrolo [2,3-d] pyrimidine compounds and its composition and use
11/26/2003CN1128789C Benzocycloheptathiophene compounds
11/26/2003CN1128788C Benzyl(idene)-lactam derivatives, their prepn. and their use as selective(ant) agonists of 5-HT 1A and/or 5-HT 1D receptors
11/26/2003CN1128634C Pure Chinese medicine preparation for curing hepatitis B
11/26/2003CN1128632C Traditional Chinese medicine compound preparation for treating chronic hepatitis B and preparing process
11/26/2003CN1128630C Functional tonifying health-care product produced by utilizing enzyme engineering and its producing method
11/26/2003CN1128626C Health-care medicinal wine for invigorating function of kidney and strengthening bone
11/26/2003CN1128614C Use of dichlorobenzyl alcohol for preparing a preparation for topical treatment of inflammation and preparation containing it
11/25/2003US6653508 Use treating various medical conditions, including pain
11/25/2003US6653347 For therapy
11/25/2003US6653333 Especially N-(2-ethylsulfonylamino-5-trifluoromethyl-3-pyridyl)cyclohexane; treating inflammatory bowel diseases, gastritis and peptic ulcer.
11/25/2003US6653329 Granulated pharmaceutical formulations and methods for making the same
11/25/2003US6653313 1,4-dihydropyridine compounds as bradykinin antagonists
11/25/2003US6653312 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
11/25/2003US6653310 For therapy of disease states mediated by the chemokine, Interleukin-8 (IL-8)
11/25/2003US6653301 For therapy of cancer, diabetes and Alzheimer's disease
11/25/2003US6653300 Pyrazole compounds useful as protein kinase inhibitors
11/25/2003US6653292 Stimulating Th1 pattern of immune activation, cytokine production, NK lytic activity and B cell proliferation; modulating with nucleic acid sequences containing unmethylated CpG dinucleotides
11/25/2003US6653133 Antisense modulation of Fas mediated signaling
11/25/2003US6652856 Method for the treatment of fibrosis
11/25/2003CA2117305C Substituted imidazole derivatives and their preparation and use
11/20/2003WO2003095678A1 Ldl receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions
11/20/2003WO2003095644A1 Novel proteins and dnas thereof
11/20/2003WO2003095637A1 Combination of a growth factor and a protease enzyme
11/20/2003WO2003095613A2 Nucleic acids, polypeptides, and methods for modulating apoptosis
11/20/2003WO2003095471A2 Deoxycholic acid derivatives for the treatment of acute dysfunctions of portal and hepatic venous circulation
11/20/2003WO2003095453A1 Compounds against helicobacter activity
11/20/2003WO2003095434A1 Benzoxazine derivatives as 5-ht6 modulators and uses thereof
11/20/2003WO2003095433A1 Hexahydro-pyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and preparation methods thereof
11/20/2003WO2003095428A1 Dopamine receptor modulators as antipsychotic agents
11/20/2003WO2003094952A1 Intratumorally administered lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
11/20/2003WO2003094946A1 Hepatoprotective activity of 2'-p-hydroxybenzoylmussaenosidic acid
11/20/2003WO2003094941A1 Traditional chinese pharmaceutical formulation for treatment of paradentosis, process for preparation and use thereof
11/20/2003WO2003094912A1 Bislactone derivative and use thereof in medicinal composition
11/20/2003WO2003094911A1 Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin
11/20/2003WO2003094905A1 Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders
11/20/2003WO2003094878A1 Gallocatechin gallate-containing composition
11/20/2003WO2003094861A2 Bis-benzimidazoles and related compounds as potassium channel modulators
11/20/2003WO2003094859A2 Epha2 monoclonal antibodies and methods of use thereof
11/20/2003WO2003094831A2 Novel diazabicyclic biaryl derivatives
11/20/2003WO2003094830A2 Novel azacyclic ethynyl derivatives
11/20/2003WO2003070192A9 Compositions and methods for surrogate antibody modulation of an immune response and transport
11/20/2003WO2003066572B1 Polyamine compounds and compositions for use in conjunction with cancer therapy
11/20/2003WO2003054012A3 Leptin proteins
11/20/2003WO2003049752A3 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
11/20/2003WO2003044172A3 Composition comprising and method of using angiopoietin-like protein 3 angptl3
11/20/2003WO2003039465A3 Treating canker sores with patches to speed healing and relieve pain
11/20/2003WO2003027076A3 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity
11/20/2003WO2003022804A3 Method for the preparation of crystalline tetrahydrobenzothiepines
11/20/2003WO2003017946A3 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof
11/20/2003WO2003016468A3 Antagonistic anti-htnfsf13b human antibodies
11/20/2003WO2003008444A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
11/20/2003WO2003004613A3 Novel pgc-1 isoforms and uses therefor
11/20/2003WO2003000864A3 Nucleic acid-associated proteins
11/20/2003WO2003000699A8 Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives as medicaments for the treatment of pain
11/20/2003WO2003000021A3 Pancam nucleic acids and polypeptides
11/20/2003WO2002102315A3 QUINAZOLINE AND PYRIDO[2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7
11/20/2003WO2002095011A3 Inactivation of genes of the mep pathway
11/20/2003WO2002090530A3 Kinases and phosphatases
11/20/2003WO2002087583B1 Use of hiv-protease inhibitors to block cell migration and/or invasion, tissue infiltration and oedema formation
11/20/2003WO2002083736A3 G-protein coupled receptor molecules and uses thereof
11/20/2003WO2002079249A3 New polynucleotides and polypeptides of the ifn$g(a)-21 gene
11/20/2003WO2002061110A8 Nucleic acid derivatives
11/20/2003WO2002038744A3 Proteases
11/20/2003US20030216811 Vascularization enhanced graft constructs
11/20/2003US20030216470 Method for treating ileus
11/20/2003US20030216469 Cyclic amino acid derivatives useful as pharmaceutical agents
11/20/2003US20030216465 Anti-constipation composition
11/20/2003US20030216445 Osteoporosis; immunosuppressants; wound healing agent
11/20/2003US20030216438 Antimicrobial agent
11/20/2003US20030216433 Gastrointestinal disorders; serotonine receptor antagonist; side effect reduction
11/20/2003US20030216427 Amine derivatives for the treatment of apoptosis
11/20/2003US20030216420 Pharmaceutical composition for treating fecal incontinence and anal itch
11/20/2003US20030216417 Substituted anilino-quinoline compounds and use thereof
11/20/2003US20030216413 Catecholamine pharmaceutical compositions and methods
11/20/2003US20030216408 -4-substituted-N-(2-(4-(2,3-dihydro-benzo(1,4)dioxin-5-yl)-piperazin -1-yl)propy l)-N-pyridin-2-yl-benzamide or salt; useful as 5-HT1A receptor antagonists
11/20/2003US20030216404 Hydroxamic acid derivatives
11/20/2003US20030216401 Anti-obesity 1, 2, 3, 4, 10, 10a-hexahydropyrazino[1, 2-a] indoles
11/20/2003US20030216393 Administering to a patient in need an effective pain treating amount of a substituted 1-aminobutan-3-ol compound to treat migraines, hyperalgesia, inflammatory pain, and post-operative pain
11/20/2003US20030216390 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues
11/20/2003US20030216387 Benzamide derivatives, particularly esterified cisapride derivatives
11/20/2003US20030216383 Compounds useful as reversible inhibitors of cysteine proteases
11/20/2003US20030216382 Useful for the treatment and/or prophylaxis of diseases associated with dipeptidyl peptidase, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance
11/20/2003US20030216381 Can bind to Prostaglandin E2 receptors, especially, EP3 receptor and/or EP4 receptor and show antagonizing activity, and may be useful for prevention and/or treatment of disease, for example, pain, allergy, Alzheimer's disease, cancer
11/20/2003US20030216375 Sulfonamide substituted diphenyl thiourea compounds; use thereof in treating IL-8, GRO alpha, GRO beta, GRO gamma, NAP-2, and ENA-78 mediated diseases
11/20/2003US20030216367 In perimenopausal, menopausal, and postmenopausal women through the sequential administration of combinations of conjugated estrogens and trimegestone
11/20/2003US20030216340 Methods of suppressing hepatitis virus infection using immunomodulatory polynucleotide sequences
11/20/2003US20030216292 Effects of glucagon-like peptide-1 (7-36) on antro-pyloro-duodenal motility
11/20/2003US20030215843 Screening of a novel hepatic syndrome and its uses
11/20/2003US20030215829 Nuclear hormone receptors
11/20/2003US20030215534 Mixing psyllium seeds with basic solutions, then seperating the insoluble and soluble gels, disinfecting, and acidifying to form compressible polysaccharides used as dietary fiber
11/20/2003US20030215527 Novel substituted benzimidazole dosage forms and method of using same
11/20/2003US20030215525 Heat treated suspensions comprising group III compounds, preservatives, antideposit agents and optionally adjuvants, used for prophylaxis of gastrointestinal disorders
11/20/2003US20030215501 An oral formulation containing from about 10% to 90% of a gel-forming polysaccharide derived from psyllium seed husk (containing xylose and arabinose)and 10% to about 90% of a fast dissolving excipient
11/20/2003US20030215496 Solid carrier includes a hydrophililc surfactant and a drug
11/20/2003US20030215467 Isolated from resected and washed human gastrointestinal tract; for oral administration; probiotics
1 ... 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 ... 1258